Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice

被引:509
作者
Heisler, LK
Chu, HM
Brennan, TJ
Danao, JA
Bajwa, P
Parsons, LH
Tecott, LH
机构
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA
[3] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.95.25.15049
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The brain serotonin (5-hydroxytryptamine; 5-HT) system is a powerful modulator of emotional processes and a target of medications used in the treatment of psychiatric disorders. To evaluate the contribution of serotonin 5-HT1A receptors to the regulation of these processes, we have used gene-targeting technology to generate 5-HT1A receptor-mutant mice, These animals lack functional 5-HT1A receptors as indicated by receptor autoradiography and by resistance to the hypothermic effects of the 5-HT1A receptor agonist 8-hydroxy-2- (di-n-propylamino)tetralin (8-OH-DPAT), Homozygous mutants display a consistent pattern of responses indicative of elevated anxiety levels in open-field, elevated-zero maze, and novel-object assays. Moreover, they exhibit antidepressant-like responses in a tail-suspension assay. These results indicate that the targeted disruption of the 5-HT1A receptor gene leads to heritable perturbations in the serotonergic regulation of emotional state. 5-HT1A receptor-null mutant mice have potential as a model for investigating mechanisms through which serotonergic systems modulate affective state and mediate the actions of psychiatric drugs.
引用
收藏
页码:15049 / 15054
页数:6
相关论文
共 39 条
[1]   5-HT1A RECEPTORS IN THE MEDIAN RAPHE NUCLEUS AND DORSAL HIPPOCAMPUS MAY MEDIATE ANXIOLYTIC AND ANXIOGENIC BEHAVIORS RESPECTIVELY [J].
ANDREWS, N ;
HOGG, S ;
GONZALEZ, LE ;
FILE, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (03) :259-264
[2]   Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists [J].
Artigas, F ;
Romero, L ;
deMontigny, C ;
Blier, P .
TRENDS IN NEUROSCIENCES, 1996, 19 (09) :378-383
[3]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[4]   COMPARISON OF DIFFERENT BEHAVIORAL-TEST SITUATIONS USED IN PSYCHOPHARMACOLOGY FOR MEASUREMENT OF ANXIETY [J].
BELZUNG, C ;
LEPAPE, G .
PHYSIOLOGY & BEHAVIOR, 1994, 56 (03) :623-628
[5]  
Blier P, 1998, J CLIN PSYCHIAT, V59, P16
[6]  
BLIER P, 1987, J CLIN PSYCHOPHARM, V7, pS24
[7]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[8]  
Bloom FE., 1995, PSYCHOPHARMACOLOGY 4
[9]   Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice .2. WAY 100635, SDZ 216-525 and NAN-190 [J].
Cao, BJ ;
Rodgers, RJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (02) :593-603
[10]  
CHAMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156